Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

The US Food and Drug Administration (FDA) has stood by an earlier decision confirming that the tirzepatide shortage is over.

Among the most-read coverage for the annual meeting were presentations on the potential and costs of cell and gene therapies, ...

Obesity and family practice experts share when it’s safe to prescribe GLP-1 receptor agonists to patients with thyroid ...

The NHS has released an online tool to help patients check if they are eligible for certain weight loss medications - use the ...

ImageGlass is free for both personal and commercial use, except the Store version. If you intend to use ImageGlass at your place of business or for commercial ...

MSD already has a GLP-1RA/glucagon receptor co-agonist for the treatment of MASH. Image credit: Shutterstock / Tada Images. Merck & Co (MSD) has entered an exclusive global licence agreement with ...

Patients with type 2 diabetes who use semaglutide have more than double the risk of severe optic nerve damage than those who ...

While other food and beverage trends burst onto the scene in 2024, gut health has been bubbling away quietly for some time.

By Vijay Kumar Malesu GLP-1 receptor agonists emerge as promising therapies for MASLD, addressing metabolic dysfunction and ...

New research found that some anti-obesity medications such as Wegovy and Zepbound may prompt people to drink less. These ...

Employers will need to disrupt the current healthcare system and existing partnerships to drive change, says Business Group ...